| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.012 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |